Produktbild: Cured II - LENT Cancer Survivorship Research And Education
- 10%

Cured II - LENT Cancer Survivorship Research And Education Late Effects on Normal Tissues

Aus der Reihe Medical Radiology
10% sparen

124,99 € UVP 139,09 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

19.10.2010

Abbildungen

XII, 62 illus., 42 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Philip Rubin + weitere

Verlag

Springer Berlin

Seitenzahl

180

Maße (L/B/H)

28/21/1,1 cm

Gewicht

485 g

Auflage

Softcover reprint of hardcover 1st edition 2008

Sprache

Englisch

ISBN

978-3-642-09510-8

Beschreibung

Rezension

From the reviews:"The book examines mechanisms of action and causes of both early and late radiotherapy consequences. … Written for oncologists, particularly radiation oncologists, the book is appropriate for attendings, residents, and fellows in all oncology specialties. The authors/contributors are world leaders in oncology. … This is a very well organized and written book, succinct yet strikingly informative. This series should be in every radiation oncologist’s personal library and is full of insight for those in other oncology specialties." (James G. Douglas, Doody’s Review Service, June, 2009)"There are 14 chapters written by well-known experts in the field: all of whom share the common target of striving to describe, how cancer patients can be cured by radiation therapy, chemotherapy and biological adjuvants. … This is very important when one considers time and life spans of patient cohorts … . Not only the radiotherapist but also the clinicians and all those who take care of cancer patients will appreciate … this book." (Giampiero Beluffi, La Radiologia Media, Vol. 114, 2009)“Cured II.LENT Cancer Survivorship Research and Education is the second volume concerning late effects of radiation therapy in normal tissues. … The text covers a larger range of issues, both physical and biological, written by notable experts in the field of radiobiology. … provide invaluable information for training and practising oncologists. Thoroughly recommended reading material.” (John Glaholm, RAD Magazine, November, 2010)

Portrait

Herr Professor Dr. Michael Molls leitet die Universitätsklinik für Strahlentherapie und radiologische Onkologie am Klinikum rechts der Isar in München.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

19.10.2010

Abbildungen

XII, 62 illus., 42 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Verlag

Springer Berlin

Seitenzahl

180

Maße (L/B/H)

28/21/1,1 cm

Gewicht

485 g

Auflage

Softcover reprint of hardcover 1st edition 2008

Sprache

Englisch

ISBN

978-3-642-09510-8

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Cured II - LENT Cancer Survivorship Research And Education
  • The ABCDs of the CURED Biocontinuum.- Conceptual Frameworks, Theories, Models, and Methodologic Issues.- Biodetection and Biointervention: Cytokine Pathways as a Rationale for Anticytokine Interventions Post-Radiation.- Bioimaging in Vivo to Discern the Evolution of Late Effects Temporally and Spatially.- The Potential of Single Nucleotide Polymorphisms (SNPs) to Assess Host Genomics Pre- and Post-Therapy to Determine Risks for Late Effects.- Understanding Radiotherapy-Induced Second Cancers.- Bioengineering in the Repair of Irradiated Normal Tissue by Bone Marrow Derived Stem Cell Populations.- The QARC Operation to Quality Control and Evaluate Digital Data in Clinical Trials.- Screening for Second Malignant Tumors in the Gastrointestinal Tract in Patients Irradiated for Pelvic and Abdominal Cancers.- Post-Radiation Dysphagia and Dose Volume Histogram Analysis.- Lithium as a Differential Radioprotector Following Brain Irradiation.- Serial Endocrine Profiles in Survivors of CNS Tumors who have been Irradiated.- Risk Factors for Second Malignancies in Patients who Have Undergone Stem Cell Transplant.- Risks and Surveillance for Second Malignant Tumors in Prostate and Bladder Cancer Survivors.- Cardiopulmonary Injury in Survivors of Lymphoma and the Rationale for Amelioration with Exercise.- Long Term Cardiovascular Complications in Hodgkin Lymphoma Post Combined Modality Treatment.- Equal Treatment Results in Equal Outcomes: Does Race Influence the Susceptibility to Late Effects Following Cancer Therapy?.-Cross-Linkages in Radiation Bioterror and Cancer Survivorship Late Effects Research.-CONCURED: Defining the Leading Edge in Research of Adverse Effects of Cancer Treatment.- Subject Index.- List of Contributors.